Shanghai Sanyou Medical Co., Ltd (SHA:688085)

Market Cap	4.73B -15.3%
Revenue (ttm)	549.93M +13.7%
Net Income	57.33M +117.3%
EPS	0.15 +94.0%
Shares Out	366.81M
PE Ratio	84.14
Forward PE	46.49
Dividend	0.02 (0.15%)
Ex-Dividend Date	Jun 11, 2026

Volume	n/a
Open	12.18
Previous Close	11.97
Day's Range	11.85 - 13.00
52-Week Range	11.12 - 23.76
Beta	-0.00
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About Shanghai Sanyou Medical

Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and trauma implants, including shoulder and elbow system, hip and pelvis system, knee joint system, foot and ankle, and palm and wrist systems. It also offers sports medicine. Shanghai Sanyou Medical Co., Lt...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 539
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688085

Financial Performance

In 2025, Shanghai Sanyou Medical's revenue was 542.79 million, an increase of 19.66% compared to the previous year's 453.60 million. Earnings were 63.10 million, an increase of 450.20%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 1, 2026

Data Sources Report a data error